| 2023 | | A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m6A Modification to Blood Biomarkers | 은정우, 정재연 |
| 2023 | | Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma | 김봉완, 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2016 | | Blood Neutrophil-to-Lymphocyte Ratio predicts tumor recurrence in patients with hepatocellular carcinoma within Milan criteria after hepatectomy | 왕희정, 호석광 |
| 2007 | | Bone Metastasis from Primary Hepatocellular Carcinoma: Characteristics of Soft Tissue Formation | 강승희, 오영택, 왕희정, 전미선, 조성원 |
| 2023 | | Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib | 김석휘, 김순선, 김영배, 은정우, 임수빈, 정재연, 조효정 |
| 2020 | | Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2010 | | Clinical and Pathologic Characteristics of Hepatocellular Carcinoma following Resection according to the Tumor Size | 왕희정, 조성연, 최진혁 |
| 2016 | | Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up | 정재연, 조효정 |
| 2021 | | Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers | 김순선, 은정우, 정재연, 조효정 |
| 2019 | | Effect of Fibroblast Growth Factor-2 and its Receptor Gene Polymorphisms on the Survival of Patients With Hepatitis B Virus-associated Hepatocellular Carcinoma | 김순선, 노충균, 신성재, 은정우, 이기명, 정재연, 조효정 |
| 2018 | | EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma | 김봉완, 김순선, 김영배, 노진, 노충균, 양민재, 왕희정, 윤소영, 이길호, 정재연, 조성원, 조효정, 황재철 |
| 2019 | | EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma | 노충균, 정재연 |
| 2023 | | Exosomal delivery of TRAIL and miR‑335 for the treatment of hepatocellular carcinoma (Review) | 최용준 |
| 2020 | | Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2023 | | Identification of SPP1, a cancer-associated fibroblast-derived anticancer resistance gene in hepatocellular carcinoma, and functional characterization of SORT1 as a potential driver marker for hepatocarcinogenesis | 안혜리, 조효정 |
| 2014 | | Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma | 노충균, 정재연 |
| 2019 | | Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis | 권소미, 윤계순, 이영경, 홍선미 |
| 2022 | | Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects | 우현구 |
| 2020 | | Mitochondrial Respiratory Defect Enhances Hepatoma Cell Invasiveness via STAT3/NFE2L1/STX12 Axis | 권소미, 박태준, 윤계순, 이영경, 최경숙, 홍선미 |
| 2023 | | Non-invasive markers of diagnosis and recurrence in patients with hepatocellular carcinoma | 손주아, 정재연 |
| 2020 | | Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients | 김순선, 정재연 |
| 2020 | | Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir | 김순선, 정재연 |
| 2023 | | Preoperative Balloon-Occluded Transcatheter Arterial Chemoembolization Followed by Surgical Resection: Pathological Evaluation of Necrosis | 김지훈 |
| 2023 | | Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection | 김순선 |
| 2024 | | Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area | 김순선 |
| 2020 | | Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2020 | | Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
| 2024 | | Small graft size and hepatocellular carcinoma outcomes in living donor liver transplantation: a retrospective multicentric cohort study | 김봉완 |
| 2021 | | Strategy for Selective Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation Using Right Lobe Graft | 김봉완, 홍성연 |
| 2018 | | The capsule appearance of hepatocellular carcinoma in gadoxetic acid-enhanced MR imaging: Correlation with pathology and dynamic CT | 김보현, 김영배, 김재근, 김혜진, 이다근, 이제희 |
| 2024 | | The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib | 김순선, 노충균, 박범희, 양민재, 은정우, 이길호, 임선교, 정재연, 조효정, 한지은 |
| 2018 | | Three-Dimensional Hepatocellular Carcinoma/Fibroblast Model on a Nanofibrous Membrane Mimics Tumor Cell Phenotypic Changes and Anticancer Drug Resistance | 곽종영 |
| 2023 | | Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2001 | | Urinary excretion of pseudouridine in patients with hepatocellular carcinoma, liver cirrhosis and hepatitis | 임인경, 하창영 |
| 2023 | | Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea–Japan collaborative study with 9200 patients | 김봉완 |
